This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fossum, T. W. Articles by Carney, D. H. Search for Related Content PubMed PubMed Citation Articles by Fossum, T. W. Articles by Carney, D. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Social Bookmarking                         What's this?

TP508 (Chrysalin^®) Reverses Endothelial Dysfunction and Increases Perfusion and Myocardial Function in Hearts With Chronic Ischemia

Michael E. DeBakey Institute, Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, Texas

Barbara Olszewska-Pazdrak, MD

Therapeutic Peptide Development Laboratory, Department of Biochemistry and Molecular Biology, the University of Texas Medical Branch, Galveston, Texas

Michelle M. Mertens, DVM

Michael E. DeBakey Institute, Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, Texas

Lori A. Makarski, DVM

Michael E. DeBakey Institute, Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, Texas

Matthew W. Miller, DVM, MS

Michael E. DeBakey Institute, Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, Texas

Travis W. Hein, PhD

Departments of Surgery and Ophthalmology, Scott and White Memorial Hospital, Temple, Texas

Lih Kuo, PhD

Department of Systems Biology and Translational Medicine, Texas A&M Health Science Center, Temple, Texas

Fred Clubb, DVM, PhD

Department of Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station, Texas

Gerald M. Fuller, PhD

Department of Cell Biology, University of Alabama, Birmingham, Alabama

Darrell H. Carney, PhD

Therapeutic Peptide Development Laboratory, Department of Biochemistry and Molecular Biology, the University of Texas Medical Branch, Galveston, Texas, dcarney{at}utmb.edu

Endothelial dysfunction (ED) is characterized by impaired nitric oxide (NO) signaling, decreased NO-dependent vasodilatation, increased vascular inflammation, and diminished response to angiogenic factors. TP508 (Chrysalin^®), an angiogenic tissue repair peptide, was tested for potential effects on myocardial revascularization and ED using a porcine model of chronic myocardial ischemia. TP508 increased perfusion in ischemic regions up to16-fold (P < .02) and doubled myocardial wall thickening (P < .02) relative to placebo controls. Ischemic arterioles exhibited impaired NO-mediated vasodilation and diminished NO production. TP508 reversed ischemic effects, increasing NO-mediated vasodilation (P < .05), endothelial nitric oxide synthase (eNOS) expression, and NO production. In human endothelial cells, TP508 stimulated eNOS activation (1.84 ± 0.2-fold; P < .02), increased NO production (85 ± 18%; P < .02), and prevented hypoxia-induced eNOS downregulation (P < .01). Thus, TP508 reverses ED both in porcine ischemic hearts and cultured human endothelial cells. These results suggest potential therapeutic benefit of TP508 in myocardial revascularization and treatment of ED-related diseases.

Key Words: thrombin peptide TP508 • myocardial revascularization • endothelial dysfunction • nitric oxide • human coronary artery endothelial cells

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 13, No. 3, 214-225 (2008)
DOI: 10.1177/1074248408321468


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. M. Osipov, M. P. Robich, J. Feng, R. T. Clements, Y. Liu, H. P. Glazer, J. Wagstaff, C. Bianchi, and F. W. Sellke Effect of thrombin fragment (TP508) on myocardial ischemia-reperfusion injury in hypercholesterolemic pigs J Appl Physiol, June 1, 2009; 106(6): 1993 - 2001. [Abstract] [Full Text] [PDF]

				B. Olszewska-Pazdrak, T. W. Hein, P. Olszewska, and D. H. Carney Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1162 - C1170. [Abstract] [Full Text] [PDF]

				R. M. Osipov, C. Bianchi, R. T. Clements, J. Feng, Y. Liu, S.-H. Xu, M. P. Robich, J. Wagstaff, and F. W. Sellke Thrombin Fragment (TP508) Decreases Myocardial Infarction and Apoptosis After Ischemia Reperfusion Injury. Ann. Thorac. Surg., March 1, 2009; 87(3): 786 - 793. [Abstract] [Full Text] [PDF]